Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,657 | 52,820 | 79,083 | 34,869 | 22,722 |
| Marketable Securities | N/A | N/A | N/A | N/A | 19,999 |
| Receivables | 53,821 | 42,194 | 26,267 | 11,956 | 7,296 |
| Inventories | 5,118 | 2,739 | 15,042 | 1,242 | 1,294 |
| TOTAL | $188,697 | $109,110 | $122,257 | $49,707 | $53,022 |
| Non-Current Assets | |||||
| PPE Net | 6,820 | 3,316 | 2,205 | 342 | 344 |
| Intangibles | 63,065 | 73,115 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,478 | 28,779 | 143 | 45 | 45 |
| TOTAL | $81,363 | $105,210 | $2,348 | $387 | $389 |
| Total Assets | $270,060 | $214,320 | $124,605 | $50,094 | $53,411 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,875 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 11,981 | 14,716 | 3,857 | 3,501 | 4,059 |
| Accrued Expenses | 15,391 | 25,237 | 24,405 | 12,165 | 9,671 |
| Other current liabilities | 15,055 | 1,012 | N/A | N/A | N/A |
| TOTAL | $47,302 | $40,965 | $34,262 | $22,186 | $20,315 |
| Non-Current Liabilities | |||||
| Long Term Debt | 42,905 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 6,000 | 6,520 | 6,585 |
| Other Non-Current Liabilities | 709 | 22,129 | 0 | 0 | 0 |
| TOTAL | $43,614 | $22,129 | $N/A | $N/A | $N/A |
| Total Liabilities | $90,916 | $63,094 | $34,262 | $22,186 | $20,315 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,862 | 15,227 | 15,636 | 14,037 | N/A |
| Common Shares | 16 | 16 | 15 | 14 | 14 |
| Retained earnings | 26,284 | -25,659 | -107,112 | -109,683 | -104,177 |
| Other shareholders' equity | 205 | -3 | 0 | 0 | 0 |
| TOTAL | $179,144 | $151,226 | $90,343 | $27,908 | $33,096 |
| Total Liabilities And Equity | $270,060 | $214,320 | $124,605 | $50,094 | $53,411 |